7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                   
      operating activities:
    		                   
      net income
    		3,729,000 15,653,000 -9,354,000 -31,064,000 -26,429,000 -24,003,000 -46,575,000 -47,231,000 -35,077,000 -28,494,000 -37,371,000 -56,995,000 -40,247,000 -11,580,000 -40,817,000 -47,834,000 -45,816,000 -44,762,000 -56,874,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                   
      benefit from credit loss
    		286,000   0 28,000   0 40,000 50,000 1,000 0 39,000 58,000 53,000 37,000 28,000   
      loss on right of use assets
    		      143,000             
      gain on sale of property and equipment
    		0   -1,000                
      depreciation and amortization
    		7,985,000 7,036,000 7,627,000 6,808,000 7,686,000 6,539,000 6,029,000 5,861,000 5,561,000 5,264,000 4,982,000 4,751,000 4,513,000 4,229,000 3,993,000 4,149,000 4,133,000 3,962,000 3,789,000 
      amortization-investment discount
    		-310,000 -361,000 -370,000 -495,000 -322,000 -609,000 -1,153,000  -1,633,000 -1,365,000 -351,000         
      amortization-debt issuance costs
    		440,000 441,000 440,000 315,000 366,000 92,000 520,000  303,000 429,000 305,000         
      equity-based compensation
    		16,227,000 15,553,000 17,187,000 16,236,000 17,258,000 16,784,000 20,854,000  13,569,000 15,636,000 21,978,000         
      non-cash lease expense
    		932,000 -149,000 395,000 404,000 430,000 458,000 472,000 665,000 305,000 631,000 717,000 660,000 736,000 700,000 715,000 730,000 687,000 666,000 648,000 
      changes in operating assets and liabilities:
    		                   
      accounts receivable
    		62,808,000 -69,104,000 -60,155,000 -15,052,000 44,334,000 -18,238,000 -45,322,000 -14,226,000 -16,638,000 36,301,000 -32,387,000 -4,537,000 9,769,000 -13,559,000 -26,050,000 -10,877,000 18,772,000 -16,177,000 -9,326,000 
      prepaid expenses and other current assets
    		-27,993,000 -12,533,000 -43,800,000 16,696,000 -1,588,000 1,665,000 -8,886,000 908,000 31,306,000 -19,291,000 -15,786,000 -5,614,000 -2,156,000 -1,507,000 -5,079,000 1,489,000 2,564,000 -4,846,000 -9,547,000 
      other assets
    		5,000 -29,000 -23,000 -17,000 -15,000 206,000 -114,000 -23,000 -7,000 -116,000 4,000 51,000 13,000 17,000 -167,000 636,000 2,000 12,000 -6,000 
      medical expenses payable
    		73,642,000 58,420,000 106,946,000 -7,337,000 -18,244,000 38,905,000 71,065,000 1,965,000 -3,764,000 21,528,000 15,535,000 -1,259,000 -2,476,000 18,908,000 29,077,000 -2,890,000 -7,703,000 7,036,000 16,069,000 
      accounts payable and accrued expenses
    		2,626,000 3,346,000 5,208,000 -4,295,000 1,462,000 1,325,000 48,000 -1,734,000 4,383,000 215,000 -9,211,000 11,713,000 5,182,000 -1,496,000 -1,656,000 880,000 1,925,000 -2,070,000 -298,000 
      deferred premium revenue
    		-72,000 -80,000 157,000  194,000 -251,000 -59,000  -1,135,000 6,396,000 140,773,000         
      accrued compensation
    		5,264,000 10,662,000 -7,577,000 5,980,000 1,117,000 1,227,000 -2,505,000 -1,030,000 9,236,000 1,334,000 -2,966,000 -3,875,000 6,544,000 1,304,000 -364,000 -5,882,000 7,167,000 1,162,000 -3,691,000 
      lease liabilities
    		-1,013,000 85,000 -65,000 -33,000 -71,000 -666,000 -755,000 -888,000 -457,000 -1,052,000 -1,113,000 -1,088,000 -1,098,000 -1,002,000 -1,026,000 -1,038,000 -991,000 -956,000 -832,000 
      net cash from operating activities
    		144,556,000 29,130,000 16,616,000 -8,711,000 26,190,000 23,529,000 -6,238,000 -187,466,000 5,992,000 37,177,000 85,110,000 -149,263,000 105,120,000 10,354,000 -11,638,000 -30,134,000 12,914,000 -23,449,000 -38,107,000 
      capex
    		-5,497,000 -8,003,000 -8,252,000 -9,284,000 -9,280,000 -11,733,000 -11,121,000 -10,597,000 -9,553,000 -8,560,000 -7,285,000 -6,457,000 -6,548,000 -5,855,000 -4,914,000 -2,951,000 -5,947,000 -5,016,000 -4,446,000 
      free cash flows
    		139,059,000 21,127,000 8,364,000 -17,995,000 16,910,000 11,796,000 -17,359,000 -198,063,000 -3,561,000 28,617,000 77,825,000 -155,720,000 98,572,000 4,499,000 -16,552,000 -33,085,000 6,967,000 -28,465,000 -42,553,000 
      investing activities:
    		                   
      purchase of investments
    		-10,193,000 -17,096,000 -17,905,000 -6,676,000 -35,524,000 -18,436,000 -21,564,000 -97,476,000 -124,639,000 -52,700,000 -104,243,000 0 -1,725,000 -250,000 -850,000 0 -1,675,000 -50,000 -750,000 
      sale of property and equipment
    		0   0                
      maturities of investments
    		18,005,000 17,295,000 22,695,000 10,040,000 20,230,000 57,135,000 75,390,000             
      sale of business
    		0                   
      acquisition of property and equipment
    		-5,497,000 -8,003,000 -8,252,000 -9,284,000 -9,280,000 -11,733,000 -11,121,000 -10,597,000 -9,553,000 -8,560,000 -7,285,000 -6,457,000 -6,548,000 -5,855,000 -4,914,000 -2,951,000 -5,947,000 -5,016,000 -4,446,000 
      net cash from investing activities
    		2,315,000 -6,664,000 -3,462,000 -5,920,000 -24,560,000 26,966,000 42,705,000 -1,018,000 -9,607,000 -26,210,000 -110,428,000 -8,107,000 -8,128,000 -5,855,000 -6,127,000 -2,951,000 -6,997,000 -6,421,000 -4,446,000 
      financing activities:
    		                   
      proceeds from long-term debt
    		   330,000,000 0               
      payment of employment taxes related to release of restricted stock
    		   0 0 0 -350,000             
      debt issuance costs
    		0 0 -26,000 -8,280,000 0       -595,000        
      proceeds from stock option exercises
    		948,000 1,616,000 207,000                 
      contributions from noncontrolling interest holders
    		   0 0 0 15,000 45,000 0 30,000 30,000         
      net cash from financing activities
    		948,000 1,616,000 181,000 106,875,000 0 49,488,000 -335,000 45,000 0 30,000 30,000 -527,000 17,220,000   0 0 -3,529,000 363,659,000 
      net increase in cash
    		147,819,000 24,082,000 13,335,000 92,244,000 1,630,000 99,983,000 36,132,000     -157,897,000 114,212,000 4,399,000 -17,765,000 -33,085,000 5,917,000 -33,399,000 321,106,000 
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 434,942,000 0 0 0 204,954,000 0 0 0 411,299,000         
      cash, cash equivalents and restricted cash at end of period
    		147,819,000 24,082,000 448,277,000 92,244,000 1,630,000 99,983,000 241,086,000 -188,439,000 -3,615,000 10,997,000 386,011,000         
      supplemental disclosure of cash flow information:
    		                   
      cash paid for interest
    		0   6,555,000 5,355,000 5,072,000 5,175,000 5,222,000 4,957,000 4,709,000 4,277,000 0 16,882,000 2,807,000 2,758,000 2,799,000 2,780,000 2,731,000 2,682,000 
      supplemental non-cash investing and financing activities:
    		                   
      acquisition of property in accounts payable
    		-38,000 32,000 85,000 -42,000 -10,000 -34,000 156,000 -58,000 75,000 32,000 10,000 -243,000 58,000 -99,000 331,000 -91,000 20,000 -56,000 474,000 
      cash and cash equivalents
    		147,801,000 24,082,000 446,184,000 92,559,000 1,293,000 100,104,000 238,903,000 -188,739,000 -3,615,000 10,997,000 384,261,000         
      restricted cash in other assets
    		18,000 0 2,093,000 -315,000 337,000 -121,000 2,183,000 300,000 0 0 1,750,000 0 0 0 1,750,000 800,000 50,000   
      total
    		147,819,000 24,082,000 448,277,000 92,244,000 1,630,000 99,983,000 241,086,000 -188,439,000 -3,615,000 10,997,000 386,011,000 -157,897,000 114,212,000 4,399,000 450,585,000 -33,085,000 5,917,000 -33,399,000 528,917,000 
      (gain) loss on right of use assets
    		                   
      amortization of payment-in-kind interest
    		           0        
      loss on disposal of property and equipment
    		                   
      loss on extinguishment of debt
    		           0        
      payment-in-kind interest
    		           0 -16,292,000 1,100,000 1,070,000 1,079,000 1,064,000 1,039,000 1,015,000 
      purchase of business, net of cash received
    		           -1,650,000 -1,280,000 0 -1,113,000     
      repurchase of noncontrolling interest
    		           0 0       
      repayment of long-term debt
    		           0        
      proceeds from exercise of stock options
    		                   
      purchase of business in accounts payable
    		           130,000 135,000 0 240,000     
      debt issuance costs in accounts payable
    		                   
      gain on right of use assets
    		    -8,000               
      amortization-debt issuance costs and investment discount
    		           242,000 468,000 574,000 566,000 573,000 571,000 560,000 550,000 
      equity-based compensation and common stock payments
    		           22,885,000 18,687,000 12,099,000 28,047,000 28,814,000 30,511,000 30,887,000 20,388,000 
      asset acquisition, net of cash received
    		               0 0   
      sale of investments
    		         35,050,000 1,100,000 0 1,425,000 250,000 750,000 0 625,000 50,000 750,000 
      equity repurchase
    		               0 0 0 -1,474,000 
      issuance of long-term debt
    		           0        
      issuance of common stock
    		               0 0 0 390,600,000 
      common stock issuance costs
    		               0 0 -3,544,000 -25,467,000 
      (gain) loss on sublease
    		        0           
      net decrease in cash
    		        -3,615,000 10,997,000 -25,288,000         
      loss on sublease
    		           0 1,000       
      noncurrent liabilities
    		                   
      proceeds from the sale of property and equipment
    		                   
      cash and restricted cash at beginning of period
    		           0 0 0 468,350,000 0 0 0 207,811,000 
      cash and restricted cash at end of period
    		           -157,897,000 114,212,000 4,399,000 450,585,000 -33,085,000 5,917,000 -33,399,000 528,917,000 
      cash
    		           -157,897,000 114,212,000 4,399,000 448,835,000 -33,885,000 5,867,000 -33,799,000 528,417,000 
      common stock issuance costs included in accounts payable and accrued expenses
    		                  3,532,000 
      purchase of noncontrolling interest
    		               0 0   
      benefit from doubtful accounts
    		                  8,000 
      restricted cash in restricted and other assets
    		                  500,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.